Literature DB >> 33122101

α-Gal on Crotalidae-polyvalent Fab antivenom (CroFab): Investigating the relevance to immediate hypersensitivity reactions.

Matthew Straesser1, Behnam Keshavarz1, Larry Borish2, Dilawar Khokhar1, Angela Holian3, Nathan P Charlton3, Thomas A E Platts-Mills1, Jeffrey M Wilson4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33122101      PMCID： PMC7870545          DOI： 10.1016/j.jaip.2020.10.026

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

1.  Acute hypersensitivity reaction to Crotalidae polyvalent immune Fab (CroFab) as initial presentation of galactose-α-1,3-galactose (α-gal) allergy.

Authors:  Justin Rizer; Kaitlin Brill; Nathan Charlton; Joshua King
Journal:  Clin Toxicol (Phila)       Date:  2017-04-26       Impact factor: 4.467

2.  Investigation into the α-Gal Syndrome: Characteristics of 261 Children and Adults Reporting Red Meat Allergy.

Authors:  Jeffrey M Wilson; Alexander J Schuyler; Lisa Workman; Monica Gupta; Hayley R James; Jonathon Posthumus; Emily C McGowan; Scott P Commins; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol Pract       Date:  2019-03-30

3.  Incidence of allergic reactions to Crotalidae polyvalent immune Fab.

Authors:  Moteb Khobrani; Yvonne Huckleberry; Keith J Boesen; Ahmed Aljabri; Mobarak Alharthi; Asad E Patanwala
Journal:  Clin Toxicol (Phila)       Date:  2018-09-27       Impact factor: 4.467

4.  Acute adverse events associated with the administration of Crotalidae polyvalent immune Fab antivenom within the North American Snakebite Registry.

Authors:  Kurt Kleinschmidt; Anne-Michelle Ruha; Sharan Campleman; Jeffrey Brent; Paul Wax
Journal:  Clin Toxicol (Phila)       Date:  2018-04-24       Impact factor: 4.467

5.  Alpha-gal is a possible target of IgE-mediated reactivity to antivenom.

Authors:  J Fischer; B Eberlein; C Hilger; F Eyer; S Eyerich; M Ollert; T Biedermann
Journal:  Allergy       Date:  2016-11-21       Impact factor: 13.146

6.  On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy.

Authors:  Thomas A E Platts-Mills; Scott P Commins; Tilo Biedermann; Marianne van Hage; Michael Levin; Lisa A Beck; Maria Diuk-Wasser; Uta Jappe; Danijela Apostolovic; Michael Minnicozzi; Marshall Plaut; Jeffrey M Wilson
Journal:  J Allergy Clin Immunol       Date:  2020-02-10       Impact factor: 10.793

Review 7.  Venomous snakebites in the United States: management review and update.

Authors:  Gregory Juckett; John G Hancox
Journal:  Am Fam Physician       Date:  2002-04-01       Impact factor: 3.292

8.  Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis.

Authors:  Tammi H Schaeffer; Vaishali Khatri; Liza M Reifler; Eric J Lavonas
Journal:  Acad Emerg Med       Date:  2012-02       Impact factor: 3.451

9.  A dynamic relationship between two regional causes of IgE-mediated anaphylaxis: α-Gal syndrome and imported fire ant.

Authors:  Jeffrey M Wilson; Behnam Keshavarz; Maya Retterer; Lisa J Workman; Alexander J Schuyler; Emily C McGowan; Charles Lane; Alaaddin Kandeel; Jane Purser; Eva Rönmark; Joseph LaRussa; Scott P Commins; Tina Merritt; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2020-06-06       Impact factor: 10.793
  9 in total
  2 in total

Review 1.  Alpha-Gal Syndrome in Children: Peculiarities of a "Tick-Borne" Allergic Disease.

Authors:  Francesca Saretta; Mattia Giovannini; Francesca Mori; Stefania Arasi; Lucia Liotti; Luca Pecoraro; Simona Barni; Riccardo Castagnoli; Carla Mastrorilli; Lucia Caminiti; Gian Luigi Marseglia; Elio Novembre
Journal:  Front Pediatr       Date:  2021-12-23       Impact factor: 3.418

Review 2.  The Meat of the Matter: Understanding and Managing Alpha-Gal Syndrome.

Authors:  Jessica D Macdougall; Kevin O Thomas; Onyinye I Iweala
Journal:  Immunotargets Ther       Date:  2022-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.